Methadone and sleep apnea syndrome;Méthadone et syndrome d'apnées du sommeil

Canadian Journal of Psychiatry

Volumn 50, Issue 3, 2005, Pages 153-158

  Durst, Philippe ^a   Palazzolo, Jérôme ^b,d   Peyrelong, Jean Pierre ^a   Berger, Michel ^a   Chalabreysse, Michel ^a   Billiard, Michel ^c   Vialle, André ^e  

^a Centre Hospitalier Sainte Marie   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

^c GUI DE CHAULIAC HOSPITAL   (France)

^d CH Sainte Marie   (France)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALIMEMAZINE; BENZODIAZEPINE; BROMOCRIPTINE; CLONIDINE; HYDROXYZINE; LEVOMEPROMAZINE; METHADONE; OPIATE; PAROXETINE; TEMAZEPAM;

ADULT; ARTICLE; BREATHING; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HUMAN; POLYSOMNOGRAPHY; SLEEP; SLEEP APNEA SYNDROME; SLEEP DISORDER; SNORING; STEROID THERAPY;

EID: 17144418978     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370505000304     Document Type: Article

References (28)

1. Palazzolo J. Neurobiologie des fonctions du sommeil et de ses troubles. Application à la clinique psychiatrique. Ann Psychiatrie 2000;15:50-7.
2. Palazzolo J. Troubles du sommeil et prescription d'hypnotiques: données actuelles et perspectives. Nervure 2001;14(6):13-7.
3. Palazzolo J, Tourte M, Chabannes JP. Oxygénothérapie au long cours et pathologie psychiatrique. Nervure 1996;(8):25-8.
4. Dyer O. Doctors should do more for drug addicts, committee says. BMJ 2002;324:1295.
5. Tarumi Y, Pereira J, Watanabe S. Methadone and fluconazole: respiratory depression by drug interaction. J Pain Symptom Manage 2002;23:148-53.
6. Schlitt SC, Schroeter LM, Wilson FE, Olsen GD. Methadone-induced respiratory depression in the dog: comparison of steady-state and rebreathing techniques and correlation with serum drug concentration. J Pharmacol Exp Ther 1978;207:109-22.
7. Hamunen K. Ventilatory effects of morphine, pethidine and methadone in children. Br J Anaesth 1993;70:414-8.
8. Prieto IJ, Poyo-Guerrero R, Fernández R, Ochoa E. Ultrarapid high-dose methadone detoxification. Psychopharmacology 2003;165:430.
9. Sporer KA. Strategies for preventing heroin overdose. BMJ 2003;326:442-4.
10. Walsh SL, Preston KL, Bigelow GE, Stitzer ML. Acute administration of buprenorphine in humans: partial agonist and blockade effects. J Pharmacol Exp Ther 1995;274:361-72.
11. Seifert J, Metzner C, Paetzold W, Borsutzky M, Passie T, Rollnik J, et autres. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs methadone. Pharmacopsychiatry 2002;35:159-64.
12. Lyvers M, Yakimoff M. Neuropsychological correlates of opioid dependence and withdrawal. Addict Behav 2003;28:605-61.
13. Farney RJ, Walker JM, Cloward TV, Rhondeau S. Sleep-disordered breathing associated with long-term opioid therapy. Chest 2003;123:632-9.
14. Mintzer MZ, Stitzer ML. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend 2002;67:41-51.
15. Krieger J. Les syndromes d'apnées du sommeil. In: Billiard M, éditeur. Le sommeil normal et pathologique. 2e édition. Paris: Masson; 1998. p 417-47.
16. Watanabe S, Tarumi Y, Oneschuk D, Lawlor P. Opioid rotation to methadone: proceed with caution. J Clin Oncol 2002;20:2409-10.
17. Eich-Hochli D, Oppliger R, Golay KP, Baumann P, Eap CB. Methadone maintenance treatment and St John's wort-a case report. Pharmacopsychiatry 2003;36:35-7.
18. Eap CB, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet 2002;41:1153-93.
19. Xie A, Wong B, Phillipson EA, Slutsky AS, Bradley TD. Interaction of hyperventilation and arousal in the pathogenesis of idiopathic central sleep apnea. Am J Respir Crit Care Med 1994;158:489-95.
20. Javaheri S, Parker TJ, Wexler L, Liming JD, Lindower P, Roselle GA. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996;335:562-7.
21. Shinsuke S, Hitoshi M, Osamu H. Involvement of adenosine A2A receptor in sleep promotion. Europ J Pharm 1998;351:155-62.
22. Weitzenblum E, Chaouat A, Charpentier C, Ehrhart M, Kessler R, Schinkewitch P, et autres. Sleep-related hypoxaemia in chronic obstructive pulmonary disease: causes, consequences and treatment. Respiration 1997;64:187-93.
23. Badr MS, Toiber F, Skatrud JB, Dempsey J. Pharyngeal narrowing/occlusion during central sleep apnea. J Appl Physiol 1995;78:1806-15.
24. Hudgel DW, Harasick T. Fluctuation in timing of upper airway and chest wall inspiratory muscle activity in obstructive sleep apnea. J Appl Physiol 1990;69:443-50.
25. Montplaisir J, Nicolas A, Lapierre O. Les impatiences musculaires de l'éveil et les mouvements périodiques des jambes au cours du sommeil. In: Billiard M, editeur. Le sommeil normal et pathologique. 2e édition. Paris: Masson; 1998. p 475-81.
26. Carley DW, Radulovacki M. Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat. Am J Respir Crit Care Med 1999;160:1824-9.
27. Palazzolo J. Observance médicamenteuse et psychiatrie. Paris: Elsevier; 2004.
28. Palazzolo J. Dire pour vivre. Pathologies psychiques: témoignages au quotidien. Paris: Ellebore; 2004.